Midgard Science

Labs / Assays & in vitro testing

Gubra

Hørsholm, Denmark · gubra.dk

GLP

On your own

Free. Their own form.

Contact Gubra directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Gubra is a biotech company in Hørsholm, Denmark, with additional sites in Boston, United States, and Basel, Switzerland. It provides preclinical CRO services, drug discovery and development focused on peptide therapeutics, and venture creation and incubation. Its CRO work serves pharmaceutical and biotech companies worldwide.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Preclinical contract research services

    Preclinical studies to help pharmaceutical and biotech companies advance drug development pipelines.

  • Liver (MASH) studies

    Validated MASH mouse models and related translational endpoints for efficacy and proof-of-concept work.

  • Obesity studies

    Diet-induced obesity rodent models and efficacy studies with metabolic and body composition endpoints.

  • Kidney disease studies

    Preclinical models for CKD, DKD and AKI with pharmacology, biomarkers, histology and 3D imaging.

  • Lung (IPF) studies

    Bleomycin-induced IPF mouse models with pulmonary function, histopathology and transcriptomic readouts.

  • Diabetes studies

    Preclinical diabetes assessment services using disease models and translational endpoints.

  • Women’s health studies

    Preclinical studies in POI and PCOS models to assess novel compounds.

  • Muscle (sarcopenia) studies

    Integrated muscle research platform for profiling drug candidates in sarcopenia-related work.

  • Non-rodent studies

    PK, NGS and bioinformatics studies in miniature pigs.

  • 3D imaging services

    3D imaging to visualize and quantify effects in organs, including brain and whole kidney.

  • 2D histology

    Histology services for tissue analysis and endpoint quantification.

  • RNAseq services

    RNA sequencing services to investigate molecular mode of action and transcriptomic profiles.

  • Peptide drug discovery

    AI-assisted peptide discovery and optimization from target identification through candidate selection.

  • Drug development

    Pharmaceutical development, preclinical development, IND-enabling activities and clinical development to clinical proof of concept.

  • Venture creation and incubation

    Builds asset-centric biotech ventures around externally sourced opportunities.

What they work on

Modalities
Small molecule, Antibody, Peptide, Viral vector
Species and models
mouse, rat, miniature pig, C57BL/6J mice, DIO mouse, DIO rat, GAN DIO-MASH mouse, CDAA-HFD mouse, UUO mouse, ADI CKD mouse, uIRI mouse, 5/6 nephrectomy rat, and 2 more
Assays and studies
in vivo pharmacology, ex vivo assays, drug profiling, 2D histology, 3D whole brain imaging, whole organ imaging, energy expenditure, metabolic profiling, body composition, acute food intake monitoring, biomarker analysis, full metabolic assessment, and 3 more
Instruments and platforms
AI-based histology pipeline, whole body plethysmography, spirometry, 3D imaging technologies, GubraView
Scale and capacity
more than 300 scientists and experts
Therapeutic areas
Liver (MASH), Obesity, Kidney, Lung (IPF), CNS, Diabetes, Women’s Health, Muscle (Sarcopenia)
Type
CRDMO
Sites
Hørsholm, Denmark · Boston, United States · Basel, Switzerland
Team
more than 300 scientists and experts
Quality
AALAC-I accreditation (animal research program) · Quality management system (data integrity and controlled documentation)
Serves
worldwide, global partners
Address
2 Stonecutter Street) or via Webcast. Presentaion (PDF) Webcast video London and online In
Founded
2020

Similar labs. EyeCRO, Sparx BIO, Syd Labs, Allumiqs

Found in a contract services directory. Listing built from gubra.dk. Work here? Claim this listing.

Gubra · Midgard Science